" />
English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 4 April 2014, 13:02 HKT/SGT
Share:
Barclays Initiates Coverage of CMGE with an Overweight Rating and a 12-month Price Target of US$32

HONG KONG, Apr 4, 2014 - (ACN Newswire) - Barclays initiates coverage of China Mobile Games and Entertainment Group Limited ("CMGE" or the "Company") (Nasdaq: CMGE), the largest publisher and a leading developer of mobile games in China, with an Overweight rating and a 12-month price target of US$32.

Barclays issued a detailed report on CMGE on April 3, 2014. CMGE is given an Overweight rating and a 12-month price target of US$32, given its: 1) leading position in integrated mobile games publishing and development; 2) extensive and diversified games portfolio; and 3) multifaceted publishing channels/platforms. We expect potential share price catalysts from: 1) overseas expansion initiatives; 2) the traction and revenue opportunity from 51PK.com; and 3) the rising penetration of its Game Center app via MediaTek's handsets. Our US$32 price target is based on 15x our 2015E non-GAAP EPADS of US$2.13, implying a PEG ratio of 0.19x, which we believe is reasonable considering the hit-or-miss nature of new games' success, the shorter life cycle of mobile games, and potential execution risks.

Barclays believes that CMGE's integrated publishing and self-development model leads to a more diversified game portfolio and lower concentration of revenues compared to its peers. CMGE operates a total of 717 game titles, with 72 social games and 645 single player games as of end-2013. It plans to launch c50 new social games in 2014, 15 of which are to be self-developed. The contribution of social games to CMGE's revenue increased from 17.6% in 2012 to 63% in 2013.

Also, multifaceted publishing channels present good value proposition to developers. CMGE's broad and solid relationships with various distribution partners/platforms (including third-party app stores, telcos, chipset and handset manufacturers), as well as its in-house knowledge of games development, mean it presents a strong value proposition to small, fragmented mobile games developers.


Topic: Press release summary Sectors: Daily Finance, IT Individual, Daily News
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
GIC Invests US$100M in Ascletis Pharma (1672. HK): Anchoring Long-Term Capital in China's Core Innovative Drug Assets  
Feb 6, 2026 17:45 HKT/SGT
GIC Private Limited initiated a stake in Ascletis Pharma (01672) by 64,128,000 shares at a price of HKD 12.18 per share  
Feb 6, 2026 17:01 HKT/SGT
COSMOPlat Introduces Full-Stack AI to Hong Kong for Trillion-Dollar Industrial Digitalization  
Feb 6, 2026 16:34 HKT/SGT
Everest Medicines Announces China NMPA Approval of VELSIPITY(R) for Adults with Moderately to Severely Active Ulcerative Colitis  
Feb 6, 2026 14:17 HKT/SGT
Spritzer Celebrates Continued Excellence with Dual Recognition at Putra Brand Awards 2025 and Superior Taste Award 2025  
Feb 6, 2026 13:13 HKT/SGT
Mitsubishi Motors Launches the All-New Versa Van in the Philippine Market  
Friday, February 6, 2026 12:34:00 PM
Eternal Beauty Holdings Limited and Lane Crawford Debut Landmark Fragrance, Further Expanding Footprint in High-Margin Niche Fragrance Market  
Feb 6, 2026 12:21 HKT/SGT
Distinct Healthcare Successfully Listed on HKEX, Bolstered by Premium Customer Base and All-Star Cornerstone Investors  
Feb 6, 2026 11:44 HKT/SGT
Establishment of the World's First*1 Global Supply Chain to Introduce the Use of Renewable Plastics in Sony's High-Performance Products  
Friday, February 6, 2026 10:50:00 AM
Eisai and Henlius Enter into Exclusive Commercial License Agreement for Anti-PD-1 Antibody Serplulimab in Japan  
Friday, February 6, 2026 10:31:00 AM
More Press release >>
 Events:
More events >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575